These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Central infusion of aldosterone synthase inhibitor attenuates left ventricular dysfunction and remodelling in rats after myocardial infarction. Huang BS; White RA; Ahmad M; Tan J; Jeng AY; Leenen FH Cardiovasc Res; 2009 Feb; 81(3):574-81. PubMed ID: 18689429 [TBL] [Abstract][Full Text] [Related]
5. Fiftieth anniversary of aldosterone: from discovery to cardiovascular therapy. Tan LB; Schlosshan D; Barker D Int J Cardiol; 2004 Sep; 96(3):321-33. PubMed ID: 15310530 [TBL] [Abstract][Full Text] [Related]
6. Persistent cardiac aldosterone synthesis in angiotensin II type 1A receptor-knockout mice after myocardial infarction. Katada J; Meguro T; Saito H; Ohashi A; Anzai T; Ogawa S; Yoshikawa T Circulation; 2005 May; 111(17):2157-64. PubMed ID: 15851599 [TBL] [Abstract][Full Text] [Related]
7. The role of the renin-angiotensin-aldosterone system in heart failure. Unger T; Li J J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5 Suppl 1():S7-10. PubMed ID: 15526242 [TBL] [Abstract][Full Text] [Related]
8. Prevention of cardiac remodeling after myocardial infarction in transgenic rats deficient in brain angiotensinogen. Lal A; Veinot JP; Ganten D; Leenen FH J Mol Cell Cardiol; 2005 Sep; 39(3):521-9. PubMed ID: 15950985 [TBL] [Abstract][Full Text] [Related]
9. Critical role of CNS effects of aldosterone in cardiac remodeling post-myocardial infarction in rats. Lal A; Veinot JP; Leenen FH Cardiovasc Res; 2004 Dec; 64(3):437-47. PubMed ID: 15537497 [TBL] [Abstract][Full Text] [Related]
10. Pathophysiology of heart failure following myocardial infarction. Struthers AD Heart; 2005 May; 91 Suppl 2(Suppl 2):ii14-6; discussion ii31, ii43-8. PubMed ID: 15831601 [TBL] [Abstract][Full Text] [Related]
12. Eplerenone: hypertension, heart failure and the importance of mineralocorticoid receptor blockade. Funder JW Future Cardiol; 2006 Sep; 2(5):535-41. PubMed ID: 19804189 [TBL] [Abstract][Full Text] [Related]
13. [Rationale, characteristics and study design of PREAMI (Perindopril and Remodelling in the Elderly with Acute Myocardial Infraction)]. Magrini G; Nicolosi GL; Chiariello M; Ferrari R; Remme P; Tavazzi L Ital Heart J; 2005 Nov; 6 Suppl 7():14S-23S. PubMed ID: 16485513 [TBL] [Abstract][Full Text] [Related]
14. Cardioprotection by aldosterone receptor antagonism in heart failure. Part I. The role of aldosterone in heart failure. Dieterich HA; Wendt C; Saborowski F Fiziol Cheloveka; 2005; 31(6):97-105. PubMed ID: 16366159 [TBL] [Abstract][Full Text] [Related]
16. Role of aldosterone blockade for treatment of heart failure and post-acute myocardial infarction. Greenberg B; Zannad F; Pitt B Am J Cardiol; 2006 May; 97(10A):34F-40F. PubMed ID: 16698333 [TBL] [Abstract][Full Text] [Related]
17. [Effects of aldosterone receptor blocker therapy on cardiac remodeling]. Boccanelli A; Battagliese A G Ital Nefrol; 2006; 23 Suppl 34():S57-63. PubMed ID: 16633997 [TBL] [Abstract][Full Text] [Related]
18. Cardiovascular effects of aldosterone and post-acute myocardial infarction pathophysiology. Cohn JN; Colucci W Am J Cardiol; 2006 May; 97(10A):4F-12F. PubMed ID: 16698330 [TBL] [Abstract][Full Text] [Related]
19. Hemodynamic and neurohormonal predictors and consequences of the development of atrial fibrillation in dogs with chronic heart failure. Tisdale JE; Borzak S; Sabbah HN; Shimoyama H; Goldstein S J Card Fail; 2006 Dec; 12(9):747-51. PubMed ID: 17174237 [TBL] [Abstract][Full Text] [Related]
20. [The AREA IN-CHF trial (antiremodeling effect of aldosterone receptors blockade with canrenone in mild chronic heart failure): rationale and design]. Cacciatore G; Boccanelli A; Mureddu GF; Maggioni AP; Latini R; Masson S; de Simone G; Ital Heart J; 2005 May; 6 Suppl 1():66S-74S. PubMed ID: 15945301 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]